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Abstract
Introduction: There is increasingly a double burden of under-nutrition and obesity in women of reproductive age.
Preconception underweight or overweight, short stature and micronutrient deficiencies all contribute to excess
maternal and fetal complications during pregnancy.
Methods: A systematic review and meta-analysis of the evidence was conducted to ascertain the possible impact
of preconception care for adolescents, women and couples of reproductive age on maternal, newborn and child
health (MNCH) outcomes. A comprehensive strategy was used to search electronic reference libraries, and both
observational and clinical controlled trials were included. Cross-referencing and a separate search strategy for each
preconception risk and intervention ensured wider study capture.
Results: Maternal pre-pregnancy weight is a significant factor in the preconception period with underweight
contributing to a 32% higher risk of preterm birth, and obesity more than doubling the risk for preeclampsia,
gestational diabetes. Overweight women are more likely to undergo a Cesarean delivery, and their newborns have
higher chances of being born with a neural tube or congenital heart defect. Among nutrition-specific interventions,
preconception folic acid supplementation has the strongest evidence of effect, preventing 69% of recurrent neural
tube defects. Multiple micronutrient supplementation shows promise to reduce the rates of congenital anomalies
and risk of preeclampsia. Although over 40% of women worldwide are anemic in the preconception period, only
one study has shown a risk for low birth weight.
Conclusion: All women, but especially those who become pregnant in adolescence or have closely-spaced
pregnancies (inter-pregnancy interval less than six months), require nutritional assessment and appropriate
intervention in the preconception period with an emphasis on optimizing maternal body mass index and
micronutrient reserves. Increasing coverage of nutrition-specific and nutrition-sensitive strategies (such as food
fortification; integration of nutrition initiatives with other maternal and child health interventions; and community
based platforms) is necessary among adolescent girls and women of reproductive age. The effectiveness of
interventions will need to be simultaneously monitored, and form the basis for the development of improved
delivery strategies and new nutritional interventions.
Introduction
Nutritional status is an important aspect of health and
wellness before and during pregnancy. Under nutrition in
women contributes to 20% of maternal deaths, and is a
significant risk factor for stillbirths, preterm births, small
for gestational age and low birth weight babies [1-7], yet
in most countries 10-20% of women are underweight [8].
Maternal short stature heightens the risk for obstructed
labor, obstetric fistula and maternal mortality, as well as
birth asphyxia leading to neonatal death, and is often the
result of girls being stunted since childhood [9]. Pre-
pregnancy overweight and obesity has been linked to two
of the foremost causes of maternal mortality [10,11] -
hypertensive disorders of pregnancy [12-15] and gesta-
tional diabetes mellitus (GDM) [16,17]- as well as an
entire spectrum of adverse pregnancy outcomes [1-7],
including poor lactation practices [18,19], obstetric
anesthesia-related complications [20], prolonged gesta-
tion [21,22], maternal infectious morbidity [23] and
decreased success with trial of labor [24-27]. Maternal
obesity is a cause for stillbirths, fetal and neonatal death* Correspondence: zulfiqar.bhutta@aku.eduDivision of Women and Child Health, Aga Khan University Karachi, Pakistan
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[3,28-31], and moreover, perpetuates the obesity epi-
demic since children of obese women are more likely to
be obese themselves [17,32-36].
In addition to weight, micronutrient status is also
linked to pregnancy outcomes. The recent Cochrane
review [37] found a strong protective effect (RR 0.28,
95% CI 0.15-0.52) of folic acid on recurrent neural tube
defects (NTDs). Other meta-analyses of randomized and
observational studies showed a reduction in recurrence
risk of 69 to 100% [38] and a reduction in occurrence
risk of 42 [39] to 62% [40], yet less than half of all
women regularly consume folic acid before conception
[41]. Despite research evidence linking iron deficiency
with maternal mortality, around 40% of women are ane-
mic globally [9]. Other micronutrients such as zinc and
calcium have been found to improve maternal and new-
born outcomes when supplementation is provided dur-
ing pregnancy- it seems likely that ensuring adequate
intake of these micronutrients earlier, which is during
the preconception period, would be of added benefit for
undernourished girls and women and in the case of
unplanned pregnancies. Folic acid, B vitamins and zinc
have been shown to affect early fetal development, even
before women realize they are pregnant. Micronutrient
supplementation or fortification is currently being used
as strategies to improve nutrition even in resource-poor
settings since many girls and women are chronically
undernourished [42].
There is a dearth of intervention trials to address under-
nutrition or obesity in women of reproductive age. Weight
and micronutrient status during pregnancy is influenced
by a number of factors such as food insecurity and birth
spacing that require broad interventions, hence the aim
should to achieve and sustain optimal nutritional intake
and weight before pregnancy. In addition, even for women
who are overweight or obese, losing weight is not recom-
mended during gestation and therefore weight and nutri-
tional status should be reviewed between pregnancies.
Nutritional risks and interventions are an important com-
ponent of preconception care, defined for the purpose of
this review as “any intervention provided to women and
couples of childbearing age, regardless of pregnancy status
or desire, before pregnancy, to improve health outcomes
for women, newborns and children” (Detailed discussion
of the importance and scope of preconception care is
given elsewhere) [43].
This paper presents the findings of a systematic review
that was undertaken to consolidate the evidence for
nutritional risks before pregnancy, and ascertain the
effectiveness of providing interventions during the pre-
conception period (versus periconception or prenatal)
on maternal, newborn and child health (MNCH) out-
comes. The first section discusses pre-pregnancy weight,
which is followed by diet and exercise as interventions
to achieve and maintain optimal weight. This is followed
by the sections on folic acid, multivitamin and iron sup-
plementation in the preconception period. The review
also looks beyond efficacy of an intervention to studies
that examined impact of strategies used to increase
uptake.
Methods
We systematically reviewed all literature published up to
2011 to identify studies describing the effectiveness of
preconception (period before pregnancy and between
pregnancies) nutritional risks and interventions and their
impact on maternal, newborn and child health (MNCH)
outcomes. Electronic databases such as PubMed,
Cochrane Libraries, Embase, and WHO Regional Data-
bases were searched to identify the studies. We included
systematic reviews, experimental and observational stu-
dies. Papers were also identified by hand searching refer-
ences from included studies. No language or date
restrictions were applied in the search. The findings were
presented at international meeting [44,45] and shared
with professionals in the relevant fields of maternal and
child health, following which results were updated based
on current searches (through end of 2012) and expert
opinion. Studies were included if they reported the nutri-
tional risks and interventions for MNCH outcomes.
Methodology is described in detail elsewhere [43].
For the studies that met the final inclusion criteria,
two review authors abstracted data describing study
identifiers and context, study design, intervention speci-
fics and outcome effects into a standardized abstraction
sheets. The quality of experimental studies were
assessed using Cochrane criteria [46], whereas STROBE
guidelines were used to assess the quality of observa-
tional studies [47]. We conducted meta-analyses for
individual studies and pooled statistics was reported as
the odds ratio (OR) and relative risk (RR) between the
experimental and control groups with 95% confidence
intervals (CI). Mantel–Haenszel pooled RR and corre-
sponding 95% CI were reported or the Der Simonian–
Laird pooled RR and corresponding 95% CI where there
was an unexplained heterogeneity. All analyses were
conducted using the software Review Manager 5.1 [48].
Heterogeneity was quantified by Chi2 and I2, in situa-
tions of high heterogeneity, causes were explored and
random effect models were used.
Results
The review identified 2034 papers from search in all data-
bases. After the initial title and abstract screening, 198 full
texts were reviewed to identify papers which met the
inclusion criteria and had the outcomes of our interest.
One hundred and forty six studies were finally selected for
abstraction and analysis (Figure 1). Information related to
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In order to define the categories of weight that are not
normal, the World Health Organization and the
National Institutes of Health grouped weight into four
categories according to individuals’ body mass index:
underweight (<18.5 kg/m2), normal (18.5–24.9 kg/m2),
overweight (25.0-29.9 kg/m2), and obese (30.0 kg/m2)
[49]. The literature shows a BMI-dependent relationship
between pre-pregnancy obesity and adverse pregnancy
outcomes [50,51]. Further, excessive postpartum weight
retention is a risk not only for subsequent pregnancies
[52,53], but also for the development of maternal
chronic diseases. Although guidelines exist for gesta-
tional weight gain according to maternal pre-pregnancy
BMI, however gestational weight gain is not discussed
further as it falls outside the scope of preconception
care. Previous reviews have assessed maternal over-
weight and obesity using various cutoff points to define
obesity, and have linked them to only one outcome of
interest. This review extensively examines any MNCH
outcomes that have been reported with all weight cate-
gories, grouping the data from individual studies into
underweight or overweight and comparing these to
women with normal BMI as defined above (please see
table for data included here).
The review identified 34 studies that discussed maternal
underweight [11,13,15,30,31,54-81]. This review found
that pre-pregnancy underweight significantly increases the
risk of preterm birth by 32% (RR 1.32, 95% CI 1.22-1.43)
(Figure 2). Pre-pregnancy underweight was also found to
significantly increase the risk of small-for-gestational age
babies (RR 1.64, 95% CI 1.22-2.21)., Although previous
work has found a significant effect of pre-pregnancy
underweight on the risk of having low birth weight babies
(RR 1.64 [82] and OR 1.82 [83], this review found a non-
significant risk (RR 1.37, 95% CI 0.46-4.13) perhaps
because of the low number of studies included since these
were the only ones to assess maternal weight status before
pregnancy. No effect was found for pre-pregnancy under-
weight on hypertensive disorders of pregnancy, GDM,
large-for-gestational age or macrosomia, or any congenital
birth defects.
The review identified 41 studies that reported out-
comes for overweight women [1,7,11,13,15,29,54-60,
63-67,71-81,84-89]. The results presented in this review
for the increased risk of hypertensive disorders of preg-
nancy with maternal overweight are not truly represen-
tative of the association since various studies categorized
this outcome differently. The risk of preeclampsia (OR
2.28; 95% CI: 2.04-2.55) (Figure 3) and GDM (OR 1.91;
95% CI: 1.58-2.32), however, approximately doubles with
Figure 1 Search flow diagram
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pre-pregnancy overweight, and the effect was even
greater for pre-pregnancy obesity. The data for impact of
pre-pregnancy obesity is not presented since it is similar
to the results for maternal overweight. The Pooled analy-
sis of seven observational studies showed a clear increase
of 42% in caesarean delivery among overweight women
(OR 1.42, 95% CI 1.21-1.66). This review found inconclu-
sive evidence for the effect of pre-pregnancy overweight
on preterm births, instrumental delivery, or fetal distress.
Perinatal outcomes that were significantly associated
with maternal overweight before conception include
macrosomia, large-for-gestational age babies (OR 1.63,
95% CI 1.51-1.76), and birth defects-notably neural tube
defects and congenital heart defects (OR 1.15, 95% CI
1.07-1.24).
Nutritional interventions
Diet, exercise and weight loss
Consumption of calorie-dense but nutritiously poor foods
and physical inactivity are concerning for the health of all
Figure 2 Pre pregnancy underweight and risk for preterm birth: evidence from observational studies Citations to the included studies:
Abenhaim 2007 [55], Chen 2009 [56], Driul 2008 [57], Johnson 2009 [58], Kosa 2010 [59], Murakami 2005 [60], Ronnenberg 2003 [61], Salihu 2009
[62], Wise 2010[63], Chen 2010 [64], Gilboa 2008 [65], Han 2010 [66].
Figure 3 Pre pregnancy overweight and risk for preeclampsia: evidence from observational studies Citations to the included studies:
Abenhaim 2007 [55], Driul 2008 [57], Fortner 2009 [75], Murakami 2005 [60], Nohr 2008 [67], Cedergren 2004 [29], Chen 2010 [64], Doherty 2006
[11], Leeners 2006 [13], LaCoursiere 2005 [74], Phithakwatchara 2007 [85], Sebire 2001[1]
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people, but disproportionately affect mothers and their
young children. Fortunately, weight is a modifiable risk
factor and evidence supports weight change as an inter-
vention to improve MNCH outcomes [50,51,56,73,90].
Although this review demonstrated that maternal under-
weight increases the chances of preterm birth (25%), and
small-for-gestational age babies (64%), the review found a
scarcity of evidence for interventions to improve the
macro-nutritional status of women before pregnancy.
As shown in the previous section, maternal overweight
and obesity is a major risk factor for poor maternal and
child outcomes. There is some evidence to support exer-
cise as an intervention to decrease the risk of GDM,
preeclampsia, and maternal weight gain, improve birth
weight, and increase the chance of a normal delivery
[91]. This review expands upon previous work [92,93]
and examines whether diet and/or exercise are effective
in reducing weight in women, and if this impacts
MNCH outcomes.
The review 23 identified studies [94-116]. The trials found
all used a control group; however they were carried out in
women of different ages, and included different interven-
tions. Women in the intervention group lost an average of
up to 3.5kg. Interventions that combined calorie restriction
and physical activity, involved a support system and moni-
toring, and were sustained over longer periods effected
more weight change. A case control study [96] showed that
women with perceived strenuous physical activity before
pregnancy had a 78% reduced risk of preeclampsia.
Folic acid supplementation
Folic acid is a B-vitamin whose bioavailability from dietary
sources lags behind that achieved through supplementa-
tion, and whose deficiency is associated with congenital
abnormalities, especially neural tube defects [117]. Multiple
case-control, cohort and quasi-randomised controlled trials
have been carried out that provide a strong evidence base
to support the effectiveness of folic acid supplementation
in preventing birth defects and their consequent morbidity
and mortality. Folic acid supplementation has thus become
a primary periconceptional intervention.
The analyses showed that folic acid has a strong protec-
tive effect on preventing recurrent NTDs (RR 0.31, 95% CI
0.14-0.66) when it was restricted to randomized double-
blind placebo-controlled studies, however this effect was
no longer significant when two observational studies were
included- (RR 0.43, 95% CI 0.13-1.40) (Figure 4). The
review also found a significant effect of multivitamin sup-
plementation in preventing NTDs, both occurrent and
recurrent, although the only included study that did not
show a beneficial effect actually separated folic acid from
multivitamins, while the rest included folic-acid containing
supplements. Hence, it is doubtful that multivitamins
without folic acid have a protective effect against NTDs,
which is confirmed by the MRC study (RR for multivita-
mins versus placebo 0.61, 95% CI 0.26-1.45) [118].
Previous reviews have not shown a benefit of folic acid/
multivitamin supplementation on orofacial clefts, and
although this review added three case-control studies and
two prospective cohorts, the effect sizes adhered to unity.
However, reviews that include all studies on folic acid/
multivitamin supplementation simultaneously do show a
modest protective effect [123-126], especially for cleft lip.
This review identified [118-120,122,127-198] 73 studies
on the effect of folic acid supplementation and congenital
heart defects. The result is mixed at best- pooling of two
randomized trials, one cohort and one case-control trial
showed a risk reduction of 42% in this analysis (Figure 5).
No review has shown a consistent effect of folic acid/
multivitamin supplementation on maternal and preg-
nancy outcomes- including ectopic pregnancy, miscar-
riage, stillbirths, preterm births, low birth weight, and
other birth defects. Further, the apprehension that wide-
spread folic acid supplementation or fortification would
lead to increased rates of multiple gestation was not
shown to be significant in this review (RR 0.99, 95% CI
Figure 4 Folic acid supplementation and risk of recurrent neural tube defects: evidence from observational and experimental studies
Citations to the included studies: Kirke 1992 [119], Laurence 1981 [120], MRC 1991 [118], Suarez 2000 [121], Vergel 1990 [122]
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0.94-1.05) or previous work (OR 1.02 with supplementa-
tion and maximum annual increase in twinning rates of
4.6% with fortification) [199].
The results from three randomized double-blind placebo-
controlled studies yield a 69% reduced risk (RR of 0.31, 95%
CI 0.14-0.66) for recurrent NTDs with periconceptional
folic acid supplementation. The MRC study probably pro-
vides the most accurate estimate for this intervention since
it was a multicenter prospective randomized trial [118].
The remaining studies all suffer from low response rates,
however, only Suarez et al. 2000 [121] has results inconsis-
tent with the pooled analysis. This could be attributed to
recall and selection bias in the study or to primary intake in
this population being from dietary sources with lower
bioavailability.
Multivitamins supplementation
There is incontrovertible data to support the routine use
of multivitamins by women of reproductive age, to
improve their own health as well as their potential mother
and child outcomes. Although previous systematic reviews
and meta-analyses have analysed the unique role of peri-
conceptional folic acid (versus multivitamins) on MNCH
outcomes, they have included only randomised and quasi-
randomised trials. In addition, while periconceptional sup-
plementation is in itself an intervention, it would have a
greater impact if it were implemented for all women with
the potential to become mothers. For limb reduction
defects (RR ranges from 0.43-0.59 for all analyses) and
congenital urinary tract anomalies (RR ranges from 0.17-
0.68 for all analyses), the evidence shows a modest but
persistent risk reduction with the use of multivitamins,
rather than folic acid.
Pooling two cohort studies, the review also found a
significant 27% reduction in the risk of preeclampsia
(Figure 6) by maternal periconceptional multivitamin
supplementation. This review also found a 43% risk
reduction of multivitamins for multiple congenital
abnormalities (Figure 7).
Pooling data from 5 case-control and 2 cohort-con-
trolled trials conducted in relatively high-income coun-
tries (HICs), resulted in a significant 49% decrease in risk
(RR 0.51, 95% CI 0.31-0.82) (Figure 8) of occurrent
neural tube defects due to periconceptional multivitamin
supplementation. The case-control study by Bower &
Stanley 1992 was inconsistent with the other study
results, possibly owing to the small total number of
women using periconceptional multivitamins, or to recall
bias among case mothers [129]. There was substantial
heterogeneity between studies, however repeat analysis
using random effects did not change the results.
A recent community intervention in China [201] pro-
vided multivitamins to the intervention group from 3
months pre-pregnancy until the end of the first trimester.
Figure 5 Folic acid supplementation and risk of congenital heart defects: evidence from observational and experimental studies
Citations to the included studies: Botto 1996 [146], Czeizel 1996 [134], Czeizel 2004 [135], Kirke 1992 [119]
Figure 6 Multivitamin supplementation and risk of preeclampsia: evidence from observational studies Citations to the included studies:
Bodnar 2006 [155], Catov 2009 [156]
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The intervention resulted in lower incidence of stillbirth
(0.70% in intervention group vs. 1.55% in control group;
p <0.001), malformation (0.23% in intervention group vs.
0.70% in control group; p <0.001) and low birth weight
(0.39% in intervention group vs. 0.84% in control group;
p <0.001) compared to the control group, and better
growth indicators at birth.
Iron supplementation
Anemia is a common problem among women of repro-
ductive age, especially in low and middle income coun-
tries (LMICs) where low dietary intake of bioavailable
iron combined with endemic infectious diseases such
as helminthiasis puts women at increased risk in the
preconception period. Low preconception hemoglobin
and ferritin levels increase the risk of poor fetal growth
and low birth weight [202]. The literature shows that
iron supplementation during pregnancy can be a pro-
tective factor against low birth weight [203], and given
alone or with folic acid it is effective in increasing iron
stores and preventing anemia during later gestation
[204].
The review identified 6 studies [205-210]. Berger et al.
[205] tested a weekly combined iron-folic acid intervention
in the preconception period among Vietnamese women
and similarly found the supplementation significantly
improved iron status and reduced anemia when compared
to baseline. In the Philippines ferritin levels improved,
however hemoglobin lagged behind, possibly due to
women being deficient in other micronutrients related to
heme formation which were not supplemented during the
study [206]. The results of these interventions on a
national level were similar to a previous randomized-con-
trolled trial in Bangladesh [207] where iron-folic acid
given as a powdered supplement added to food decreased
anemia among non-pregnant women; however this benefit
did not extend to those women who became pregnant.
Recent trials in Vietnam [208,209] combined iron-folic
acid supplementation with intermittent deworming and
demonstrated significant reduction in anemia, lower rates
of helminthic infection, high compliance, and increase in
birth weight in intervention districts versus control. In
India, the country with the world’s highest proportion of
maternal anemia, the same intervention was carried out in
Figure 7 multivitamin supplementation and risk of multiple congenital anomalies: evidence from observational studies Citations to the
included studies: Bitsko 2007 [149], Czeizel 2003 [150], Khoury 1996 [151], Shaw 2000 [152]
Figure 8 multivitamin supplementation and risk of concurrent neural tube defects: evidence from observational studies Citations to the
included studies: Bower 1992 [129], Chen 2008[133], Czeizel 1996 [134], Czeizel 2004 [135], Mulinare 1988 [136], Shaw 1995 [200], Werler 1993 [138].
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adolescent girls, resulting in a substantial drop in anemia
prevalence [210].
Discussion
Maternal overweight and obesity is a growing problem
across the world, but women in LMICs and lower socioe-
conomic strata continue to be at risk of undernourishment
[211]. Both pre-pregnancy overweight and underweight
are risk factors for poor maternal and child health out-
comes, however overweight and obesity results in signifi-
cantly greater health risks and associated costs. This
review identified the association of maternal underweight
with preterm birth and small for gestational age babies
and the findings are comparable to previous meta-analysis
which showed an increased risk of 29% [212] and another
study which showed an increased risk of 37% [62]. Simi-
larly the results on association of pre-pregnancy over-
weight on pre-eclampsia and GDM is consistent with
previous reviews that show the risk of preeclampsia typi-
cally doubles for each 5 to 7 kg/m2 increase in BMI [213];
and the OR of developing GDM is 1.97-2.14 for over-
weight women, and 3.01-3.56 for obese women [16,214].
The pooled analysis on risk of caseation section and other
outcomes are also consistent with previous reviews
[2,6,16,215,216]. Given that weight is a modifiable risk fac-
tor, research must now focus on how healthcare interven-
tions and public health campaigns can reduce these risks.
There is a strong need for evidence to demonstrate
the effectiveness of interventions to achieve optimal pre-
pregnancy weight, especially for those women who are
underweight. This review confirms earlier evidence
[217] that promoting improvement in diet and exercise
through sustained, daily changes, with the help of a sup-
port system results in weight loss and higher levels of
physical activity. Although preceding work illustrates
examples of population-scale interventions, more
research is needed to support how small-scale initiatives
targeted at women with childbearing potential can be
implemented on a wider scale. In HICs countries, obese
women are increasingly opting to undergo weight loss
surgeries, and a review of laparoscopic adjustable gastric
banding (LAGB) shows lower gestational weight gain and
better maternal and neonatal outcomes for these women
compared to obese women not undergoing LAGB prior
to pregnancy; however the outcomes were not improved
compared to women of normal weight [218].
The role of nutrition in promoting health is well defined.
What women eat determines more than just their own
health, it is also vital to healthy pregnancies and newborns,
and in fact research now shows that nutritional status in
early childhood affects health throughout life. Pregnancy,
or planning for pregnancy, provides an impetus for
women to change non-healthful behaviors. Many women
are still unaware of how much their nutritional status
impacts their pregnancy outcomes, and improving
women’s nutrition and weight-related behaviors should
therefore begin during their earlier reproductive years.
Folic acid supplementation has been proven to reduce
the risk of NTDs, both recurrent and occurrent and the
results are confirmed by the meta-analyses undertaken by
De-Regil et al. [37] However, further research is needed to
show whether this benefit extends to prevention of orofa-
cial clefts and congenital cardiovascular abnormalities.
Although major health organizations promote the use of
folic acid by women of reproductive age through clinical
guidelines and recommendations [219], and the prevalence
of folic acid use is reportedly high in the prenatal period,
most women do not use folic acid in the periconceptional
period, even if they are aware of its benefits. A recent sys-
tematic review [41] demonstrated that even in high
income countries, only half of all women use folic acid
before conception, therefore protective levels cannot be
achieved before the critical period of neural tube closure.
Reasons for low prevalence of use are confirmed by other
studies [220-228] and include low maternal education and
socioeconomic status; young maternal age; lack of a part-
ner; and unplanned pregnancy. It is necessary therefore to
improve awareness and use of folic acid supplements
among all women of reproductive age so that even women
with unplanned pregnancies are protected.
Multicomponent interventions increase use transiently
and do not achieve universal coverage, although those
with personal counseling in addition to mass campaigns
have been shown to be more effective [229]. Fortifica-
tion has thus been proposed as a means to prevent
approximately half of all NTDs occurring annually and
13% of neonatal mortality attributed to NTDs [40],
especially in areas with high prevalence of NTDs
[230-232]. However, ongoing efforts must be made to
supplement women at risk of a recurrent NTDs and
women who are more folate-depleted [233,234]. A novel
idea has been to incorporate folate into contraceptive
pills, which also helps to bridge the gap between when a
woman discovers she is pregnant and neural tube clo-
sure, even without periconceptional folate use [235]. In
order to provide all women (including those at risk of
recurrence) with an adequate dose of folic acid, public
health policy in some countries now mandates that sta-
ple foods, such as flour, be fortified with folic acid.
The studies on iron demonstrate that large-scale
nutritional intervention is feasible in LMICs contexts,
and results in better biochemical indices. Given the glo-
bal magnitude of maternal anemia, however, it is sur-
prising that only one trial further assessed birth weight
as a measure of improved maternal and newborn health.
Iron fortification of foods such as flour, rice, sugar,
juice, and fish or soy sauce in various countries has also
been shown to improve iron status among women of
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reproductive age [236-240], but again the analyses of the
fortification trials do not assess pregnancy outcomes in
the long-term. As with folic acid, preventive iron supple-
mentation may require greater community mobilization
and social marketing for increased effectiveness [205]
and to contribute to improved women’s and maternal
health in developing regions.
Conclusion
Maternal malnutrition remains a serious global health
issue, particularly in LMICs. The median prevalence of
low body mass index among women in the preconception
period is 10.9% among 24 countries with a recent Demo-
graphic and Health Survey, while 42% of women are ane-
mic when they become pregnant [241]. Underweight and
deficiencies of essential nutrients coupled with the increas-
ing burden of obesity have consequences during preg-
nancy and for newborns. These negative effects are
amplified in adolescents or women with closely-spaced
pregnancies since they have depleted nutritional reserves,
which results in stillbirths, neonatal deaths, low birth
weight and preterm births [242]. Overweight and obesity
further predispose to maternal hypertensive disorders and
gestational diabetes.
Among nutrition-specific interventions periconceptional
folic acid supplementation significantly reduces the risk of
recurrent NTDs. There is growing interest in multiple
micronutrient supplementation in at-risk populations in
whom multiple deficiencies often coexist. Data for multi-
ple micronutrient supplementation from a small number
of controlled trials shows a persistent lowering of rates of
congenital anomalies and preeclampsia. Other nutrition-
specific interventions (iron, calcium, balanced protein
energy supplementation) have only been studied in preg-
nant women, or if they have been studied during the pre-
conception period the outcomes are limited to changes in
biochemical markers while pregnancy and birth outcomes
were not assessed.
Strategies for implementation of nutrition-specific inter-
ventions in the preconception period are needed especially
to reach women in low- and middle-income countries. At
present, food fortification with micronutrients is noted to
be the most cost-effective large scale method. However,
different approaches are needed to specifically increase
uptake among women of reproductive age, noting the criti-
cal links between poor maternal nutritional status and its
wide-ranging determinants and consequences. Nutritional-
sensitive interventions improve population health, educa-
tion and development and countries investing in such stra-
tegies have had greater gains in both nutrition and health
outcomes. Integrating nutrition with maternal and child
health initiatives and developing community-based plat-
forms that are able to reach populations are especially
promising.
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